Vancouver, BC – Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “HAVN Life”) announces that the Ontario and British Columbia Securities Commissions have issued a “failure to file” cease trade order in respect of the Company’s securities under Multilateral Instrument 11-103 Failure-to-File Cease Trade Orders in Multiple Jurisdictions (the “CTO”). …
The Company’s line of plant and mushroom-based natural health products will be available at LCL grocery banners across Canada Vancouver, BC – Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “HAVN Life”), a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural health products, is pleased …
HAVN Life Announces Retail Listing With Loblaws Company Ltd. Read More »
Vancouver, BC – Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “HAVN Life”) announces the departure of Mr. Gary Leong and Mr. Gordon Clissold as directors on the Board of the Company, effective immediately. Mr. Clissold is also departing as CFO of the Company. With Mr. Clissold’s departure, Mr Tim …
HAVN LIFE ANNOUNCES BOARD AND MANAGEMENT CHANGES Read More »
Vancouver, BC – Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “HAVN Life”) announces the departure of Mr. Tim Laidler as a director on the Board of the Company, effective immediately. On behalf of the Board, Mr. Tim Moore, Chairman of the Board, stated, “Mr. Laidler has been instrumental in …
HAVN LIFE ANNOUNCES DEPARTURE OF TIM LAIDLER AS DIRECTOR Read More »
Vancouver, BC – Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “HAVN Life”) announces that the board of directors of the Company (the “Board”), on the advice of the Company’s Chief Financial Officer, has determined that the Company is no longer a going concern as it is unable to meet …
Vancouver, BC – Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “HAVN Life”) a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural health products, is pleased to announce that it has closed the initial tranche (the “First Tranche“) of its financing commitment (the “Financing“) by …
Vancouver, BC – Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “HAVN Life”) a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural health products, is pleased to annouce that it will complete a consolidation (“Consolidation”) of its issued and outstanding common shares on the basis …
HAVN Life Announces a 30:1 Consolidation of its Common Shares Read More »
The Company is a designated supplier, providing cGMP psilocybin to Project Solace participants Vancouver, BC – Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “HAVN Life”), a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural health products, is pleased to announce its participation in Project …
Vancouver, BC – Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “HAVN Life”) a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural health products, is pleased to announce that Alpha Blue Ocean (“ABO“) is supporting the Company’s growth with a CAD$9,000,000 financing arrangement whereby the …
This new partnership will see the distribution of the Company’s standardized, naturally derived, psilocybin containing mushrooms for therapeutic use at Healing Escapes Foundation retreats in Jamaica Vancouver, BC – Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “HAVN Life”) a biotechnology company pursuing standardized extraction of psychoactive compounds and the …
HAVN Life Enters Supply Agreement with MPB Group Inc. Read More »
